YOUR BUSINESS AUTHORITY
Springfield, MO
Johnson & Johnson's COVID-19 vaccine added $502 million to its third-quarter revenue.
Revenue during the quarter was $23.3 billion, short of the $23.7 billion expected by analysts.
Adjusted earnings per share came to $2.60, beating the $2.35 per share estimate.
Read more from CNBC.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Eric Schmitt introduces Modern Skies Act
Caterpillar to acquire John Fabick Tractor Co.
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach